SARS-CoV-2 Restructures the Host Chromatin Architecture
This article has been Reviewed by the following groups
Listed in
- Evaluated articles (ScreenIT)
Abstract
SARS-CoV-2 has made >190-million infections worldwide, thus it is pivotal to understand the viral impacts on host cells. Many viruses can significantly alter host chromatin 1 , but such roles of SARS-CoV-2 are largely unknown. Here, we characterized the three-dimensional (3D) genome architecture and epigenome landscapes in human cells after SARS-CoV-2 infection, revealing remarkable restructuring of host chromatin architecture. High-resolution Hi-C 3.0 uncovered widespread A compartmental weakening and A-B mixing, together with a global reduction of intra-TAD chromatin contacts. The cohesin complex, a central organizer of the 3D genome, was significantly depleted from intra-TAD regions, supporting that SARS-CoV-2 disrupts cohesin loop extrusion. Calibrated ChIP-Seq verified chromatin restructuring by SARS-CoV-2 that is particularly manifested by a pervasive reduction of euchromatin modifications. Built on the rewired 3D genome/epigenome maps, a modified activity-by-contact model 2 highlights the transcriptional weakening of antiviral interferon response genes or virus sensors (e.g., DDX58 ) incurred by SARS-CoV-2. In contrast, pro-inflammatory genes (e.g. IL-6 ) high in severe infections were uniquely regulated by augmented H3K4me3 at their promoters. These findings illustrate how SARS-CoV-2 rewires host chromatin architecture to confer immunological gene deregulation, laying a foundation to characterize the long-term epigenomic impacts of this virus.
Article activity feed
-
SciScore for 10.1101/2021.07.20.453146: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
NIH rigor criteria are not applicable to paper type.Table 2: Resources
Antibodies Sentences Resources Then, the membranes were incubated in TBST with primary antibodies (GAPDH (Proteintech, 60004-1), RAD21 (Abcam, Ab992, Lot: GR214359-10), CTCF (Millipore, 07-729), SMC3 (Abcam, Ab9263, Lot:GR466-7), Total Histone H3 (Abcam, Ab1791, Lot:GR206754-1), H3K4me3 (Abcam, Ab8580, Lot: GR3264490-1), H3K9me3 (Abcam, Ab8898, Lot: GR164977-4), H3K27ac (Abcam, Ab4729, Lot: GR3357415-1), and H3K27me3 (Cell Signaling Technology, #9733S, Lot19)) at 4°C overnight. GAPDHsuggested: (Proteintech Cat# 60004-1-Ig, RRID:AB_2107436)RAD21suggested: (Abcam Cat# ab992, RRID:AB_2176601)CTCFsuggested: (Millipore Cat# 07-729, RRID:A…SciScore for 10.1101/2021.07.20.453146: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
NIH rigor criteria are not applicable to paper type.Table 2: Resources
Antibodies Sentences Resources Then, the membranes were incubated in TBST with primary antibodies (GAPDH (Proteintech, 60004-1), RAD21 (Abcam, Ab992, Lot: GR214359-10), CTCF (Millipore, 07-729), SMC3 (Abcam, Ab9263, Lot:GR466-7), Total Histone H3 (Abcam, Ab1791, Lot:GR206754-1), H3K4me3 (Abcam, Ab8580, Lot: GR3264490-1), H3K9me3 (Abcam, Ab8898, Lot: GR164977-4), H3K27ac (Abcam, Ab4729, Lot: GR3357415-1), and H3K27me3 (Cell Signaling Technology, #9733S, Lot19)) at 4°C overnight. GAPDHsuggested: (Proteintech Cat# 60004-1-Ig, RRID:AB_2107436)RAD21suggested: (Abcam Cat# ab992, RRID:AB_2176601)CTCFsuggested: (Millipore Cat# 07-729, RRID:AB_441965)Lot:GR466-7), Total Histone H3suggested: NoneH3K27acsuggested: (Abcam Cat# ab4729, RRID:AB_2118291)H3K27me3suggested: NoneCells were incubated with 1:500 anti-SARS-CoV-2 Spike glycoprotein antibody (Abcam, Catalog#ab272504) diluted in blocking buffer for overnight at 4 degree. anti-SARS-CoV-2 Spike glycoproteinsuggested: (Abcam Cat# ab272504, RRID:AB_2847845)The next morning, the antibody-protein-chromatin complex was retrieved by adding 25μl pre-washed Protein G Dynabeads (Thermo Fisher Scientific, 10004D). antibody-protein-chromatinsuggested: NoneThe antibodies used for ChIP-Seq include RNA Polymerase II (RPB1 N terminus, Cell Signaling Technology, #14958S, Lot4), RAD21 (Abcam, Ab992, Lot: GR214359-10), SMC3 (Abcam, Ab9263, Lot:GR466-7), CTCF (Millipore, 07-729), H3K4me3 (Abcam, Ab8580, Lot: GR3264490-1), H3K9me3 (Abcam, Ab8898, Lot: GR164977-4), H3K27ac (Abcam, Ab4729, Lot: GR3357415-1), H3K27me3 (Cell Signaling Technology, #9733S, Lot19) and HA (Abcam, Ab9110, Lot:GR3231414-3). RPB1 N terminus, Cell Signaling Technology,suggested: NoneSMC3suggested: (Abcam Cat# ab9263, RRID:AB_307122)Lot:GR466-7), CTCFsuggested: NoneH3K4me3suggested: NoneH3K9me3suggested: (Abcam Cat# ab8898, RRID:AB_306848)HAsuggested: (Abcam Cat# ab9110, RRID:AB_307019)Experimental Models: Cell Lines Sentences Resources Cell culture: Human lung adenocarcinoma cells A549 expressing human ACE2 (A549-ACE2, #NR53821) was acquired from BEI Resources (Manassas, VA). A549suggested: None293T cells were from ATCC and were cultured in DMEM with 10% FBS. 293Tsuggested: NonePrior to infection, Vero-E6 cells were washed once with PBS and the viral inoculum was added to the flask in the presence of 3 ml of serum-free and antibiotics-free MEM medium supplemented with 1mM HEPES, and incubated for 1 hour at 37°C with 5% CO2. Vero-E6suggested: NoneBriefly, ∼5 million SARS-CoV-2 infected A549-ACE2 cells were washed once with PBS to remove debris and dead cells, trypsinized off the culture plates, and were cross-linked using 1% formaldehyde for 10mins at room temperature, quenched with 0.75M Tris-HCl pH 7.5 for 5mins. A549-ACE2suggested: NoneRecombinant DNA Sentences Resources Lenti-viral Transduction and CRISPRi: We in-house generated a lentiviral construct expressing dCas9-KRAB-MeCP2 by PCR amplification of the dCas9-KRAB-MeCP2 (contains a domain of MeCP2) from pB-CAGGS-dCas9-KRAB-MeCP2 (Addgene 110824), and then insert it to the pLenti-EF1a-dCas9-VP64-2A-Blast backbone (Addgene 61425) to replace th dCas9-VP64. pB-CAGGS-dCas9-KRAB-MeCP2suggested: RRID:Addgene_110824)pLenti-EF1a-dCas9-VP64-2A-Blastsuggested: NoneTo generate lentivirus, 293T cells were transfected with the lentiviral transfer vector DNA, psPAX2 packaging and pMD2.G envelope plasmid DNA at a ratio of 4:3:1, respectively, by lipofectamine 2000. psPAX2suggested: RRID:Addgene_12260)pMD2.Gsuggested: RRID:Addgene_12259)Software and Algorithms Sentences Resources For RBP1 ChIP-Seq gene transcription quantification, hg19 RefSeq gene annotation coordinates were used. RefSeqsuggested: (RefSeq, RRID:SCR_003496)RNA-Seq analysis: RNA-Seq reads were aligned to the hg19 reference human genome or SARS-CoV-2 viral genome (NC_045512.2) with STAR v 2.7.027. STARsuggested: (STAR, RRID:SCR_004463)Differential gene expression analyses were performed with EdgeR, and genes with |FC|>2, FDR<0.05 were considered as significantly differential expressed genes. EdgeRsuggested: (edgeR, RRID:SCR_012802)The pair of reads were mapped to the human reference genome assembly hg19, and multi-mapped pairs, duplicated pairs, and other unvalid 3C pairs were filtered out following the standard procedure of HiC-Pro. HiC-Prosuggested: (HiC-Pro, RRID:SCR_017643)Compartmental domains are genomic regions with continuous positive or negative compartmental scores (E1), identified by applying HOMER tool (findHiCCompartments.pl) on E1 scores. HOMERsuggested: (HOMER, RRID:SCR_010881)We considered loops with a DESeq2 FDR <0.1 and a log2FC >0 or <0 as virus-strengthened or weakened chromatin loops. DESeq2suggested: (DESeq, RRID:SCR_000154)Statistics: qPCR data was analyzed by Prism and presented as mean±SD, which are indicated in figure legends. Prismsuggested: (PRISM, RRID:SCR_005375)Statistical analyses for sequencing data were performed with Python or R scripts. Pythonsuggested: (IPython, RRID:SCR_001658)Results from OddPub: Thank you for sharing your data.
Results from LimitationRecognizer: An explicit section about the limitations of the techniques employed in this study was not found. We encourage authors to address study limitations.Results from TrialIdentifier: No clinical trial numbers were referenced.
Results from Barzooka: We did not find any issues relating to the usage of bar graphs.
Results from JetFighter: We did not find any issues relating to colormaps.
Results from rtransparent:- Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
- Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
- No protocol registration statement was detected.
Results from scite Reference Check: We found no unreliable references.
-